Opthalmic Biomaterials (SIG)
Timeslot: Friday, April 29, 2022 - 11:30am to 12:30pm
Room: Laurel C-D, 4th Floor
The Ophthalmic Biomaterials SIG Session welcomes submissions that describe the development and/or testing of biomaterials for use in ophthalmology. This may include drug delivery strategies or cell-based approaches, regenerative medicine applications, or unique animal models that have a primary focus in preserving or restoring the form and/or function of the eye. Abstracts from related areas of research with strong applicability in the visual system may also be submitted for this SIG Session.
Abstracts will be available for download on April 27, 2022.
11:30:00 PM 273. Insight into Cellular Uptake and Transport Mechanism of PLGA Nanoparticles in Cor- nea, Marjan Azadi*, Allan David, Auburn University, Auburn, AL, USA
11:45:00 AM 274. Development of a Biocom- patible Noggin Coated Electrospun Scaffold for Use as a Corneal Bandage for Treatment of Corneal Wound Healing, Nasif Mahmood*, Eelya Sefat, Darby Roberts, Brian Gilger, DVM, Jessica Gluck, PhD, North Carolina State University, Raleigh, NC, USA
12:00:00 PM 275. 3D Printable, Covalently Crosslinked Collagen Type I with Enhanced Stability for Corneal Replacement, Lucia Brunel*, Sarah Hull, Patrik Johansson, PhD, David Myung, PhD, Sarah Heilshorn, PhD, Stanford University, Stanford, CA, USA
12:15:00 PM 276. Antioxidant Microparticles for Delivery of Erythropoietin in a Mouse Glaucoma Model, Carlise DeJulius(1)*, Sarah Naguib(2), Tonia Rex, PhD(2), Craig Duvall, PhD(1,2); (1)Vanderbilt University, Nashville, TN, USA, (2)Vanderbilt University Medical Center, Nashville, TN, USA